Upcoming IPOs: Milky Mist Dairy Food, Dhoot Transmission, Molbio Diagnostics & 5 Others Set to Open Next Week; 8 Listings Scheduled

The Indian primary market is gearing up for a busy week ahead. Multiple mainboard and SME issues are scheduled to open for subscription between August 10 and 14, 2026, while several companies are expected to make their stock market debut. Here is a complete look at the key IPOs opening next week and the listings lined up. Mainboard IPOs Opening Next Week 1. Dhoot Transmission The largest issue of the week, Dhoot Transmission aims to raise approximately ₹3,067 crore. The price band is set at ₹829–871 per share. Bidding opens on August 10 and closes on August 12. The issue includes a fresh component of ₹1,400 crore and an offer for sale of about ₹1,667 crore. Minimum lot size is 17 shares (around ₹14,807 at the upper end). Listing is tentatively scheduled for August 17. 2. Molbio Diagnostics Molbio Diagnostics will open on August 10 and close on August 12. The issue size is around ₹940 crore (₹200 crore fresh issue + ₹740 crore OFS). Price band: ₹768–807. Lot size is 18 shares (mi...

Sudarshan Chemical Industries Reports Impressive Q2 2024 Results


 Sudarshan Chemical Industries Ltd has delivered a remarkable performance in the second quarter of 2024, reflecting strong growth across key financial metrics. With significant year-on-year increases in net profit and revenue, the company continues to solidify its position in the competitive pigments market.

Financial Performance Highlights

For the quarter ending September 30, 2024, Sudarshan Chemical reported a net profit of ₹29.9 crore,representing a 67% increase from ₹17.9 crore in the same period last year. This robust growth highlights the company's effective business strategies and improved operational efficiencies.

The company also achieved a revenue increase of 16%, reaching ₹689 crore, up from ₹594.7 crore in Q2 2023. This growth is attributed to increased demand for its products and a successful expansion of its market reach.

EBITDA and Margins

Sudarshan Chemical's EBITDAfor the quarter stood at ₹923 million, compared to ₹653 million in the prior year. The EBITDA margin improved to 13.39%, up from 10.99%, signaling enhanced profitability and operational efficiency. This improvement in margins reflects the company's ability to manage costs effectively while driving revenue growth.

Strategic Acquisition of Heubach Group

In a significant move, Sudarshan Chemical announced its acquisition of the Heubach Group for €127.5 million (approximately ₹1,180 crore) earlier this month. This acquisition is expected to bolster Sudarshan's position as one of the leading global pigment manufacturers, expanding its product offerings and market reach.

Market Dynamics

Currently, Sudarshan Chemical Industries boasts a market capitalization of ₹6,681 crore, with shares trading at around ₹965. The company's fundamentals remain strong, with a return on equity (ROE) of 11.3% The stock's P/E ratio stands at 48.8, reflecting investor confidence in its growth trajectory.

Conclusion

Sudarshan Chemical Industries has showcased impressive financial results for Q2 2024, with significant growth in net profit and revenue, alongside improved margins. The strategic acquisition of the Heubach Group further positions the company for sustained growth in the global pigments market. As Sudarshan continues to innovate and expand, it remains well-poised to deliver value to its shareholders and capitalize on emerging opportunities in the industry.

Comments